BNP PARIBAS FINANCIAL MARKETS - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 98 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 2.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$127,307,000
+123.7%
26,303
+391.4%
0.00%
Q4 2019$56,902,000
-18.8%
5,353
-20.4%
0.00%
Q3 2019$70,049,000
+7.6%
6,729
+58.3%
0.00%
Q2 2019$65,110,000
-36.3%
4,250
-46.6%
0.00%
Q1 2019$102,247,000
+526.0%
7,957
+708.6%
0.00%
Q3 2018$16,334,000
+3.4%
9840.0%0.00%
Q2 2018$15,793,000
-81.5%
984
-82.3%
0.00%
Q1 2018$85,282,000
-6.6%
5,574
-4.7%
0.00%
Q4 2017$91,276,000
+254.9%
5,851
+152.5%
0.00%
Q3 2017$25,719,000
+8.7%
2,317
-9.9%
0.00%
Q2 2017$23,662,000
+7.9%
2,572
+0.3%
0.00%
Q1 2017$21,931,000
+138.0%
2,565
+197.9%
0.00%
Q4 2016$9,213,000
-24.9%
861
-23.9%
0.00%
Q3 2016$12,260,000
+177.8%
1,132
+73.6%
0.00%
Q2 2016$4,414,000
-83.8%
652
-84.9%
0.00%
Q4 2015$27,234,000
-12.3%
4,316
+22.7%
0.00%
Q3 2015$31,055,000
+103.0%
3,517
+170.5%
0.00%
Q2 2015$15,301,000
+398.7%
1,300
+513.2%
0.00%
Q1 2015$3,068,000
-71.3%
212
-75.3%
0.00%
Q3 2014$10,703,000
+362.7%
859
+628.0%
0.00%
Q4 2013$2,313,0001180.00%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 453,000$4,168,0001.58%
Eventide Asset Management 1,086,400$9,995,0000.62%
SPHERA FUNDS MANAGEMENT LTD. 300,000$2,760,0000.47%
Lyon Street Capital, LLC 125,595$1,155,0000.46%
CARL DOMINO INC 26,000$239,0000.28%
PURA VIDA INVESTMENTS, LLC 60,000$552,0000.22%
KNOTT DAVID M 41,692$384,0000.16%
SABBY MANAGEMENT, LLC 187,500$1,725,0000.11%
FARALLON CAPITAL MANAGEMENT LLC 1,157,500$10,649,0000.11%
Telemetry Investments, L.L.C. 25,000$230,0000.11%
View complete list of STEMLINE THERAPEUTICS INC shareholders